Biotech

Queensland Bauxite Ltd (ASX:QBL) Recompliance Prospectus

🕔9/28/2018 9:24:06 AM

Queensland Bauxite Ltd (ASX:QBL) Prospectus has been prepared for an offer of up to 170,000,000 new Shares at an issue price of $0.035 per Share to raise up to $5,950,000, with a minimum subscription of $1,995,000 together with one (1) free attaching Option for every two (2) Shares subscribed for and issued.

Read Full Article

Regeneus Ltd (ASX:RGS) Receives R&D Tax Incentive of $2.4M

🕔9/6/2018 9:18:09 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today reported that it has received $2.4m from the Australian Government's Research and Development tax incentive program for activities conducted during the financial year 2018.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Appoints Medical Technology Advisory Board to Guide Commercialisation of Sleep Treatment Platform

🕔9/5/2018 4:40:07 PM

Oventus Medical Ltd (ASX:OVN) is pleased to announce the appointment of a Medical Technology Advisory Board of international sleep experts to help guide the development and commercialisation of the Company's Sleep Treatment Platform.

Read Full Article

Nanollose Ltd (ASX:NC6) 2018 Annual Report

🕔8/31/2018 4:17:09 PM

Nanollose Ltd (ASX:NC6) provides the Company's 2018 Annual Report.

Read Full Article

Regeneus Ltd (ASX:RGS) FY18 Results and Business Update

🕔8/30/2018 2:32:07 PM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to provide an overview of its results for the financial year ended 30 June 2018.

Read Full Article

Regeneus Ltd (ASX:RGS) Annual Report 2018

🕔8/30/2018 2:13:22 PM

Your Directors present their report for Regeneus Ltd (ASX:RGS) and its controlled entities for the financial year ended 30 June 2018.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Letter from the Chairperson

🕔8/22/2018 9:32:46 AM

The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to present a set of proposed resolutions and explanatory statements, which will see the merger of Medical Cannabis Limited into the Company and the acquisition of MedCan Australia, enabling the Company to have all the licences and facilities currently needed, to progress the Cannabis business and humanitarian goals of the company.

Read Full Article